Vitrolife AB (publ) (STO:VITR)

Market Cap	12.10B -57.7%
Revenue (ttm)	3.44B -4.7%
Net Income	-5.01B
EPS	-37.01
Shares Out	135.42M
PE Ratio	n/a
Forward PE	19.64
Dividend	1.10 (1.23%)
Ex-Dividend Date	May 6, 2026

Volume	289,127
Average Volume	417,978
Open	89.60
Previous Close	89.35
Day's Range	89.15 - 90.75
52-Week Range	87.45 - 230.60
Beta	2.06
RSI	17.91
Earnings Date	Feb 3, 2026

About Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. The company was incorporated in 1989 and is based in Gothenburg, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1989
• Employees: 1,151
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: VITR